A phase II study of ramucirumab (IMC-1121B) in the...

Gynecologic Oncology 2014 / 09 Vol. 134; Iss. 3

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

Penson, Richard T., Moore, Kathleen M., Fleming, Gini F., Braly, Patricia, Schimp, Veronica, Nguyen, Hoa, Matulonis, Ursula A., Banerjee, Susana, Haluska, Paul, Gore, Martin, Bodurka, Diane C., Hozak,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
134
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.06.029
Date:
September, 2014
File:
PDF, 637 KB
english, 2014
Conversion to is in progress
Conversion to is failed